3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Esophageal Neoplasms
25
Rectal Neoplasms
23
Glioblastoma
23
Prostatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
17
Breast Neoplasms
17
Pancreatic Neoplasms
16
Lung Neoplasms
16
Squamous Cell Carcinoma of Head and Neck
14
Head and Neck Neoplasms
14
Neoplasms
12
Oropharyngeal Neoplasms
11
Neoplasm Metastasis
10
Esophageal Squamous Cell Carcinoma
9
Adenocarcinoma Of Esophagus
8
Uterine Cervical Neoplasms
7
Glioma
7
Triple Negative Breast Neoplasms
6
Stomach Neoplasms
6
Gliosarcoma
6
Carcinoma, Squamous Cell
6
Brain Neoplasms
6
Urinary Bladder Neoplasms
5
Nasopharyngeal Carcinoma
5
Melanoma
5
Laryngeal Neoplasms
5
Colorectal Neoplasms
5
Xerostomia
4
Sarcoma
4
Mouth Neoplasms
4
Interventions
Paclitaxel
7
Pemetrexed
3
Cisplatin
3
Carboplatin
3
pembrolizumab
2
durvalumab
2
adavosertib
2
Trastuzumab
2
Radiotherapy
2
Nivolumab
2
FANG vaccine
2
Docetaxel
2
CP protocol
2
Brachytherapy
2
ulixertinib
1
tucatinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
seribantumab
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
olaparib
1
niraparib
1
larotrectinib
1
ipatasertib
1
gedatolisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Uterine Neoplasms
×
Radiation
×
Clear all
NCT03192059
2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2
Completed
43 enrolled